An Open-label, Two-treatment Crossover Pharmacokinetic Study of Clopidogrel Hydrogen Sulfate in Healthy Male and Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Aug 2010
At a glance
- Drugs Clopidogrel (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Atherosclerosis; Congenital heart defects; Embolism and thrombosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Unstable angina pectoris
- Focus Pharmacokinetics
- Sponsors Sanofi
- 26 Aug 2010 Trial phase changed from IV to I as reported by ClinicalTrials.gov.
- 28 May 2010 New trial record